User profiles for Naveed Sattar
Naveed SattarUniversity of Glasgow Verified email at glasgow.ac.uk Cited by 254027 |
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study
N Sattar, A Gaw, O Scherbakova, I Ford, DSJ O'Reilly… - Circulation, 2003 - Am Heart Assoc
Background— The National Cholesterol Education Program (NCEP) recently proposed a
simple definition for metabolic syndrome. Information on the prospective association of this …
simple definition for metabolic syndrome. Information on the prospective association of this …
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular …
Background Glucagon-like peptide-1 (GLP-1) receptor agonists differ in their structure and
duration of action and have been studied in trials of varying sizes and with different patient …
duration of action and have been studied in trials of varying sizes and with different patient …
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
Background Whether intensive control of glucose reduces macrovascular events and all-cause
mortality in individuals with type 2 diabetes mellitus is unclear. We undertook a meta-…
mortality in individuals with type 2 diabetes mellitus is unclear. We undertook a meta-…
[HTML][HTML] Empagliflozin in heart failure with a preserved ejection fraction
Background Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization for
heart failure in patients with heart failure and a reduced ejection fraction, but their effects in …
heart failure in patients with heart failure and a reduced ejection fraction, but their effects in …
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Background Trials of statin therapy have had conflicting findings on the risk of development
of diabetes mellitus in patients given statins. We aimed to establish by a meta-analysis of …
of diabetes mellitus in patients given statins. We aimed to establish by a meta-analysis of …
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised …
Background GLP-1 receptor agonists reduce major adverse cardiovascular events (MACE)
in patients with type 2 diabetes. However, uncertainty regarding kidney outcomes persists …
in patients with type 2 diabetes. However, uncertainty regarding kidney outcomes persists …
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
…, O Scherbakova, I Ford, HA Capell, N Sattar - The Lancet, 2004 - thelancet.com
Background Rheumatoid arthritis is characterised by inflammatory synovitis, articular
destruction, and accelerated atherogenesis. HMG-CoA (3-hydroxy-3-methylglutarylcoenzyme A) …
destruction, and accelerated atherogenesis. HMG-CoA (3-hydroxy-3-methylglutarylcoenzyme A) …
Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis
N Sattar, DW McCarey, H Capell, IB McInnes - Circulation, 2003 - Am Heart Assoc
There is intense interest in mechanisms whereby low-grade inflammation could interact with
conventional and novel vascular risk factors to promote the atheromatous lesion. Patients …
conventional and novel vascular risk factors to promote the atheromatous lesion. Patients …
Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms
N Sattar, IB McInnes, JJV McMurray - Circulation, 2020 - Am Heart Assoc
Circulation. 2020; 142: 4–6. DOI: 10.1161/CIRCULATIONAHA. 120.047659 July 7, 2020 5
certain ethnicities, eg, Asians. 1 Asians often display lower cardiorespiratory fitness and carry …
certain ethnicities, eg, Asians. 1 Asians often display lower cardiorespiratory fitness and carry …
[HTML][HTML] HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Background Statins increase the risk of new-onset type 2 diabetes mellitus. We aimed to
assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3-methylglutaryl…
assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3-methylglutaryl…